Facebook IPO

Does facebook is a good investisment ? I think it's to short to say if Facebook is a good investment. One think is sure, initial share price was more heigher than the real value of the society. And with all the insider sell first day of the trading on Nasdaq, share price have down easely. One think is sure, it's not the next Google but if Facebook have a good strategy to prove to shareholders than that will be a great society for shareholder. But that will be to prove in the next year. I think it's more premedity to analyse the society.

Facebook Fb on Nasdaq loss more than 10 %

It's not a good day for facebook. The share price have lost more than 10 % this morning. The share price is stabilize between 33,50 and 34 $ with more than 104 million shares traded. It's the first day of lost of the share. Friday IPO was 38 $.

NRI Nuvo Reserch Q1 2012 Result

Yet this company had dreamed all the elements before it in order to advance its growth. However with the disappointing result of anonce and with a product that has been Temporarily rejected by the FDA, I believe that shareholders have been had by management. society increased revenues from 3.8 to 6.2 million. That it will be expected as sales of Pensaid increased. The problem with that is operating expenses. $ 2 million for expenses of sales for a company with a turnover of about 15 million per year -20,000,000. Without counting the bonuses and high salaries of dirigeants.I think this company is a joke for shareholders.

CGX Energy oyl.to to Watch

Today Watch CGX energy. The stock come to up  until ,88. Maybe they are something in the society. RSI and volume are Good.

Orbite . ort.to

The situation of the company is obcur these days. Evolves under the title speculation. Many see the analysis as a short-term $ 8 and see more during the next 2-3 years to come to $ 23-37.

Nri.to Nuvo Research inc. Result Prediction Q1

Covidien to results released its quarterly and semi-annual new this week and can already see what was going to be the results of Nuvo Research Inc.. to be released next week. We can see that on the report of Covidien, sales of pharmaceutical product which is found in the poduit Pensaid increased 34% in the quarter from 106 to 142 million. If we anayse the latest results of research Nvo inc. the last quarter 2011 product sales vefrait be around 12 million. We also pourrion see an increase in royalties that could amount to around 7 million. We would therefore increase net profit of 4 million. If everything remains equal for somewhere else, the company should have a slight loss even if the result of sales of pensaid. Research and development and overhead costs are the black beast of this company. Salaries, bonuses and benefits are much too high for this company. In short, we'll see Wednesday what the numbers say that company.

Nri.to Nuvo Research Result Q1 2012

Nuvo Research inc. on TSX market will show they Q1 2012 Thursday 3 may 2012.

SNC.TO SNC LAVALIN

Today was a tought day for stock SNC-Lavalin. The stock down since they have rumor of corruption in the company. I think it's good think because the stock is in crisis same if the company show habitualy good result. I think, according to me, than the stock will fall around maybe 30 $ before to stabilise. Presentely, stock is around 35 $ and is in down trend. When the RSI of this stock will be around 20, i think that will be a good  buy opportunity to long term.

Nuvo Reseach NRI.to FDA decision Pliaglis

FDA decision on Pliaglis are reporter today because they don't have any information on the product. It's not a bad news same if the stock price have down today. This news just want say that the answer of the FDA will be reported. Nuvo research should,against me, give the reason on their web site because the investor don't no what will be appened. As soon as the FDA will receive all the information, FDA will give the decision if Pliaglis will be approuved. More detail to come.

Good day for american market, TSX and TSX-V are neutral

During the afternoon, the markets have stabilized and limit their downward trends.The situation of U.S. markets is better off facing the TSX and TSX-V. Any sector of the TSX is doing better, as the finance sector, the telecommunications sectorwhich peaked in recent months, the consumer goods sector which peaked the last 6 months. Since March this sector is strong enough. Maybe he should wear an eyeon it to follow the next direction. The health sector remains quite strong too. The decline in the TSX over the last week is part of a lower energy and resources.These sectors have stabilized but remains bullish.

NRI.to FDA decision

Against all odds, yesterday was the date that many of us expected, the date that the FDA makes are Pliaglis verdict on the product. The company Nuvo Researchannounced that the datede césision was April 16, 2012 but no news came out.Does he need fear nothing appeared in the news, I think not. I think the decision will be revealed shortly. The company has no interest in hiding the FDA decision.However, this can be frustrating is that the company announced that the date wasApril 16 and several people looked impacience decision. The company could haveéemttre a statement saying the decision would be made soon instead of waiting for people who awaited the decision.

MaxiMarketTrading Blog and Forum: Potash corp of saskatchewan - Pot.to

MaxiMarketTrading Blog and Forum: Potash corp of saskatchewan - Pot.to: The share price of Potash Corp of Saskatchewan has declined in recent days . The title usually follows the market and as lew ...

Potash corp of saskatchewan - Pot.to

The share price of Potash Corp of Saskatchewan has declined in recent days. The title usually follows the market and as lew bear market, it is normal to see Dessendre. In the graph of Friday, April 13, 2012, we remarqu'ons that the next resistance is around $ 42 and the second in the $ 39 resistance. However, trading volumes are low during the last week versus the previous month. The RSI is recovering around 40 indicates that the title is a bit oversold but not important. If the RSI was to descend into the 20, we would have a good oportunity to buy in my opinion because it's not a bad companie, it is profitable and well managed. Demand for its product is still await you. I think the reason for the decline in recent days is the market trend.

 

NRI.to - TO WATCH

Monday, we will know the FDA's decision regarding the marketing of Piaglis the United States. This decision should affect the stock price that has stabilized at a price of $ 0.13 for some days. The company is well positioned to see its share price rise with the recent news made ​​Thursday by the directions, which shows a large increase in sales due to the problem of pensaid voltaren. Moreover, with a positive decision from the FDA position and future financial results of the first quarter due out around May or June, the company is well positioned to me that one way for hisshare price continue to grow.

Direction on potash company

Today was a difficult day on Potash company. AAA.to Allana Potash on TSX market have lose 7 % on is share price. That do 3 days than this stock down on good volume. RSI on this stock is oversold and according to me, the share price can up in the next day because he have lost more than ,15 $ now. The momentum is also low. This indicator can show than this stock is oversold.

INT.V Intertainment media inc.

What do with this stock. Low volume of transaction, share price in decline after a great rally intil 0,85, this stock is trading around 0,55 $. Next support of this  stock can be auround 0,45. The share price continue to down and is not exit of her down tendance. Lower RSI is a good news because that show than this stock is oversold  and can up in a short time. My opinion is than the share price will be stabilize in short term before we see a dirrection of this stock.
Give me your opinion.

NRI.TO Nuvo Research inc.

Since two month, NRI shares on toronto market (Nuvo Research) have really progress. 2012 will be a great year for this company. After trade to 0,05 $, the shares are now to 0,125 $. more than 100 % of profit. Reason of this progression is the voltaren problem with her gel. NRI have profit of thi problem of increase her sales. In april 16, the FDA will show if the pensaid will be aprouved. To may month, the company will show the result of the first quarter of 2012. Results must be the best result of the society because in the report of the last quarter 2011, the company show a great increase in sales because voltaren problem. 2 Greats news should do increase the shares of the society and with the great numbers of insider transaction, they are not douth than the 2 first quarter of the company will be good.


Give me your opinion.

The United States will destroy each other the same

Recent events regarding the debt of the United States beyond us all these daysand it is with this that you realize that what most affects the senate is their own personal interests and not the American people. Barack Obama is doing everything possible to avoid a default on default of payment before August 2, but representatives of each party Democrat or Republican do not want to bend andprefers to build on their ideologies. The Democrats plan is good, but the Republicans want nothing to do. Why the American people have voted you it muchRepublican. Under the Bush era, there were two wars create unnecessary debt the United States as never before, create the greatest financial crisis, cut taxes of the richest .... The representative of the Senate is not working the interests of the United States but for them. Last night, Barack Obama delivered a speech quite clear to the people to make it clear that the Republicans would once again create great disaster for their country. Good luck to the United States...

Adama Technologies Corp. (OTCBB: ADAC) think to special dividend

NEW YORK, April 21, 2011 /PRNewswire-FirstCall/ -- Adama Technologies Corp. (OTCBB: ADAC), a clean-tech company, today announced the company intends to issue a one-time special dividend to all existing shareholders pending from the sale of its rights to a renewable energy project in Bucharest.
Adama recently announced the signing of a non-binding term sheet with a purchaser seeking to acquire the rights to a renewable energy project currently held by Adama. The project under negotiation is a 2.5 Mega Watt municipal waste gasification project in Bucharest, Romania.
The two parties are negotiating around a price of approximately $15MM subject to an independent appraisal.
Due diligence by the purchaser is required to conclude by July 30, 2011.
The estimated dividend amount payable to each shareholder of one common stock is $0.06.
"Should the sale of the rights of our project proceed as expected, we will be extremely pleased to reward our shareholders with this special dividend," stated Aviram Malik, CEO of Adama Technologies. "We want to thank all of our shareholders for their continuous support and show our commitment to maximizing shareholder value as we proceed with our environmentally-friendly and commercially-viable remediation activities."
About Adama Technologies Corp.
Adama Technologies Corp. has decided to dedicate its time, abilities and means to the development of clean tech projects in various fields.
Forward-Looking Statements
This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Adama Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated in the forward-looking statements. Adama Technologies' public filings may be viewed at http://www.sec.gov.

    Contact:

    Aviram Malik, CEO
    Tel +972-54-2664031
    info@adama-tech.com
    http://www.adama-tech.com

SOURCE Adama Technologies Corporation

Read more: http://www.digitaljournal.com/pr/284717#ixzz1KDEwBBeI

Apcvz - Nasdaq To watch

As predicted, we had a big bullish signal on the title APCVZ. The title has a resistance around, $ 1215. We'll see tomorrow how will react to the track.